Unlike other subtypes of breast cancer, TNBC lacks the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), making it particularly challenging to treat. This evidence concerns the gene ESR1 and breast cancer.